Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA editing signatures identify melanoma patients who respond to Pembrolizumab or Nivolumab treatment. | Transl Oncol | 2021 | 34388693 | PubTator, text mining | PubMed |
| Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications. | Front Cell Dev Biol | 2021 | 34386490 | PubTator, text mining | PubMed |
| Developing PspCas13b-based enhanced RESCUE system, eRESCUE, with efficient RNA base editing. | Cell Commun Signal | 2021 | 34380502 | PubTator, text mining | PubMed |
| Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems. | Viruses | 2021 | 34372578 | PubTator, text mining | PubMed |
| RESIC: A Tool for Comprehensive Adenosine to Inosine RNA Editing Site Identification and Classification. | Front Genet | 2021 | 34367244 | PubTator, text mining | PubMed |
| Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells. | Cancers (Basel) | 2021 | 34359681 | PubTator, text mining | PubMed |
| An I for an A: Dynamic Regulation of Adenosine Deamination-Mediated RNA Editing. | Genes (Basel) | 2021 | 34356042 | PubTator, text mining | PubMed |
| The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets. | Front Cell Dev Biol | 2021 | 34350174 | PubTator, text mining | PubMed |
| MiREDiBase, a manually curated database of validated and putative editing events in microRNAs. | Sci Data | 2021 | 34349127 | PubTator, text mining | PubMed |
| A Novel RNA-Binding Protein Signature to Predict Clinical Outcomes and Guide Clinical Therapy in Gastric Cancer. | Front Med (Lausanne) | 2021 | 34336882 | PubTator, text mining | PubMed |
| ecRESCUE: a novel ecDHFR-regulated RESCUE system with reduced RNA off-targeting activity. | Cell Commun Signal | 2021 | 34332602 | PubTator, text mining | PubMed |
| N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses. | PLoS Biol | 2021 | 34324489 | PubTator, text mining | PubMed |
| Regulating COX10-AS1 / miR-142-5p / PAICS axis inhibits the proliferation of non-small cell lung cancer. | Bioengineered | 2021 | 34323174 | PubTator, text mining | PubMed |
| Genotoxicity and inflammatory potential of stainless steel welding fume particles: an in vitro study on standard vs Cr(VI)-reduced flux-cored wires and the role of released metals. | Arch Toxicol | 2021 | 34287684 | PubTator, text mining | PubMed |
| Epitranscriptomics: A New Layer of microRNA Regulation in Cancer. | Cancers (Basel) | 2021 | 34282776 | PubTator, text mining | PubMed |
| RNA-Seq Data for Reliable SNP Detection and Genotype Calling: Interest for Coding Variant Characterization and Cis-Regulation Analysis by Allele-Specific Expression in Livestock Species. | Front Genet | 2021 | 34262593 | PubTator, text mining | PubMed |
| Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems. | Adv Sci (Weinh) | 2021 | 34254038 | PubTator, text mining | PubMed |
| Regulation and functional consequences of mGlu4 RNA editing. | RNA | 2021 | 34244459 | PubTator, text mining | PubMed |
| The RNA editing enzyme ADAR2 restricts L1 mobility. | RNA Biol | 2021 | 34224323 | PubTator, text mining | PubMed |
| 3'-UTR Polymorphisms in Thymidylate Synthase with Colorectal Cancer Prevalence and Prognosis. | J Pers Med | 2021 | 34207922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=31